Medicament for treating HPV infection and application of medicament in preparation of medicament for treating HPV infection
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A drug and pharmacy technology, applied in the field of biomedicine, can solve the problems that no human rabies vaccine treatment reports have been retrieved, and achieve the effect of not being easy to relapse
Inactive Publication Date: 2012-04-18
LIAONING CHENGDA BIOTECH
View PDF4 Cites 2 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0009] Yet the present inventor has not yet retrieved the treatment report of human rabies vaccine to HPV infection
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0020] Embodiment 1: use rabies virus PV-2061 strain to produce human rabies vaccine
[0021] Rabies virus PV-2061 strain, inoculated in eukaryotic cells (including Vero cells, hamster kidney cells, human diploid cells, chicken embryo cells, preferably Vero cells), harvested virus liquid, inactivated, purified, added The pharmaceutically acceptable carrier is used to prepare rabies vaccine preparations for adults, and the dose is 0.5-10.5 IU / dose.
Embodiment 2
[0022] Embodiment 2: Production of human rabies vaccine with rabies virus PM strain
[0023] The PM strain of rabies virus is inoculated in eukaryotic cells (including Vero cells, hamster kidney cells, human diploid cells, chicken embryo cells, preferably human diploid cells), and the virus liquid is harvested, inactivated and purified. A pharmaceutically acceptable carrier is added to prepare a rabies vaccine preparation for adults, 0.5-10.5 IU / dose.
Embodiment 3
[0024] Embodiment 3: use rabies virus Vnukovo-32 strain to produce human rabies vaccine
[0025] Rabies virus Vnukovo-32 strain, inoculated in eukaryotic cells (including Vero cells, hamster kidney cells, human diploid cells, chicken embryo cells, preferably hamster kidney cells), harvested virus fluid, inactivated, and purified , adding a pharmaceutically acceptable carrier to prepare a rabies vaccine preparation for adults, 0.5-10.5 IU / dose.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
A medicament for treating HPV infection and an application of the medicament in the preparation of medicaments for treating HPV infection. The invention is characterized in that the active component of the medicament is rabies vaccine for human, and a pharmaceutically-acceptable carrier is added to prepare the medicament; the invention also provides an application of the medicament in the preparation of medicaments for treating HPV infection, that is, a new application of rabies vaccine for human in the preparation of medicaments for treating human papillomavirus infection. The medicament (rabies vaccine for human) for treating human papillomavirus infection provided by the invention has obvious treatment effect on human papillomavirus infection; through animal experiments and preclinical observation, the medicament has satisfied and beneficial effect, has the characteristics of safety, effectiveness, and difficult recurrence after cure, and has a treatment negative conversion rate of up to 90% for human papillomavirus infection positive patients.
Description
technical field [0001] The present invention relates to a biological product, in particular to a medicine for treating human papillomavirus (HPV) infection containing human rabies vaccine, and the use of human rabies vaccine in the preparation of medicine for treating human papillomavirus (HPV) infection The application belongs to the technical field of biomedicine. Background technique [0002] Human papillomavirus (HPV) belongs to the Papillomavirus genus of the Papillomaviridae family, and is a spherical non-enveloped small double-stranded circular DNA virus. More than 120 types have been found so far. HPV can be divided into high-risk and low-risk types according to whether it causes cancer. An epidemiological classification study in 2003 defined 15 high-risk HPV types (such as HPV-16, HPV-18) and 12 low-risk HPV types (such as HPV-6, HPV-11). [0003] HPV is a relatively common virus that spreads widely in the population, because most HPV infections cause no symptoms...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more